Baird Maintains Neutral on Tenet Healthcare, Lowers Price Target to $210

Benzinga Newsdesk www.benzinga.com Negative 71.8%

Neg 71.8% Neu 0% Pos 0%

Baird analyst Michael Ha maintains Tenet Healthcare (NYSE:THC) with a Neutral and lowers the price target from $245 to $210.